|
RNCOS Releases a New Report - Ukraine Pharma - New Opportunities for Growth
RNCOS has recently added a new Market Research Report titled, "Ukraine
Pharma - New Opportunities for Growth" to its report gallery. According to
the new research report, Ukraine promises to be one of the most lucrative
pharmaceutical markets in the world. In 2007, the Ukrainian pharmaceutical
market grew by nearly 21% to register revenues in excess of US$ 2 Billion.
The market is characterized by an increasing proportion of imported and
high-priced drugs. In 2007, the average unit price of drugs sold in Ukraine
increased by nearly 20%, strongly pushing the value of pharmaceutical sales,
despite a relatively ordinary growth in sales volume.
The future outlook of the industry also seems very positive as the market is
expected to be driven by a number of reforms recently proposed by the
government. Factors such as increasing penetration of health insurance and
increasing disposable incomes of consumers will also fuel growth. The lack
of effective price controls and high margins are also expected to lure
foreign players in this market. The country's unstable political
environment, however, will be the biggest hurdle for investments. But
overall, the market is expected to grow strongly, exceeding US$ 4.5 Billion
in revenues by 2012.
This report gives an extensive and objective analysis on the pharmaceutical
market of Ukraine. It investigates both the past and present trends in the
market, with its main focus on the future trends shaping the industry. The
study discusses the performance of both the retail and hospital segments of
the pharmaceutical market in detail and based on various present and future
indicators, analyzes the future of these segments. This report gives
valuable i nformation to manufacturers/investors planning to enter the
Ukrainian pharmaceutical market.
The Report Provides Forecasts on
- Macroeconomic Indicators
- Healthcare Indicators
- Population & Demographics
- Disease Profiles
- Total Pharmaceutical Market
- Retail Pharmaceutical Market
- Hospital Pharmaceutical Market
Key Player Profiling
"Ukraine Pharma - New Opportunities for Growth" provides brief profiling on
key players, both domestic and foreign, currently operating in the Ukraine
pharmaceutical market. This section describes the revenues and growth of
players in the total pharmaceutical market, retail market and hospital
market. Performance of key drugs in various segments of the market has also
been evaluated. Business profiles of top five players, Berlin Chemie, Sanofi
Aventis, Novartis, Arterium and Darnitsa, have also been discussed in this
report.
About RNCOS:
RNCOS, incorporated in the year 2002, is an industry research firm. We are a
team of industry experts who analyze data collected from credible sources.
We provide industry insights and analysis that helps corporations to take
timely and accurate business decision in today's globally competitive
environment.
We are running a special offer on select reports till Year end, where you
can avail our reports at discounted prices. Please click here to know more:
http://www.rncos.com/promotion.htm .
For more information visit: http://rncos.com/Report/IM161.htm
Current
Industry News: http://www.rncos.com/Blog/
Published at Investorideas.com Financial Article Feed : http://www.investorideas.com/RSS/feeds/II-Art.xml
About InvestorIdeas.com: One of the first online investor resources providing in-depth information on renewable energy, greentech and water sectors.
Become an Investorideas.com Member:Gain Exclusive Insight on Leading Sectors, Global Trends, and Insider Trading Ideas, News, Articles, renewable energy and water stocks directory.
Learn more: - click here
Disclaimer: The views and opinions expressed in the research published are those of the individual companies and writers and not necessarily those of Investorideas.comŽ, or any of the industry sector portals . At the time of publication, writers may hold positions in the stocks or companies mentioned.
Investorideas.comŽ or any of the industry sector portals cannot assure accuracy of the research presented. Investors are encouraged to research and verify facts and under no circumstances is Investorideas.comŽ endorsing the content as a recommendation to buy or sell stock.
Would you like to see your news and articles here? GO>>;;
|
